Literature DB >> 25611309

Prevalence of gastroesophageal reflux disease in children, adults, and elderly in the same community.

Eiko Okimoto1, Norihisa Ishimura1, Yoshiya Morito1, Hironobu Mikami1, Shino Shimura1, Goichi Uno1, Yuji Tamagawa1, Masahito Aimi1, Naoki Oshima1, Kousaku Kawashima1, Hideaki Kazumori2, Shuichi Sato1, Shunji Ishihara1, Yoshikazu Kinoshita1.   

Abstract

BACKGROUND AND AIM: The prevalence of gastroesophageal reflux disease (GERD) in adults is increasing in Japan as well as worldwide likely due to increasing obesity and the decreasing rate of Helicobacter pylori infection. However, data regarding the prevalence of GERD in children and adolescents in Japan are lacking. We investigated the prevalence of GERD in children, adults, and elderly living in the same community.
METHODS: We surveyed employees of Shimane University Hospital and a related facility and their families using the Gastroesophageal Reflux Disease Questionnaire (GerdQ) and Izumo Scale instruments with demographic information (age, sex, body height, and body weight) and information regarding concurrent medication being taken for GERD. The presence of GERD was defined as a GerdQ score of ≥ 8.
RESULTS: A total of 1859 subjects (771 males, 1088 females; 6-96 years old) were eligible for assessment. The prevalence of GERD in those under 20 years old was 4.4%, which was approximately one third of the rate in adults (11.6%). GERD prevalence was closely associated with obesity in adults, but not in subjects under 20 years old. GERD and other gastrointestinal symptoms frequently overlapped in both adults and younger subjects.
CONCLUSION: We found that the prevalence of GERD in subjects under 20 years of age was lower than that in adults and not associated with obesity. Nevertheless, it is important to be aware of symptoms such as heartburn and/or regurgitation when children and adolescents seek routine clinical care.
© 2015 Journal of Gastroenterology and Hepatology Foundation and Wiley Publishing Asia Pty Ltd.

Entities:  

Keywords:  GerdQ; Izumo Scale; gastroesophageal reflux disease (GERD); obesity; prevalence

Mesh:

Year:  2015        PMID: 25611309     DOI: 10.1111/jgh.12899

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  18 in total

1.  Long-term vonoprazan therapy is effective for controlling symptomatic proton pump inhibitor-resistant gastroesophageal reflux disease.

Authors:  Satoshi Shinozaki; Hiroyuki Osawa; Yoshikazu Hayashi; Yoshimasa Miura; Alan Kawarai Lefor; Hironori Yamamoto
Journal:  Biomed Rep       Date:  2021-02-01

2.  Vonoprazan 10 mg daily is effective for the treatment of patients with proton pump inhibitor-resistant gastroesophageal reflux disease.

Authors:  Satoshi Shinozaki; Hiroyuki Osawa; Yoshikazu Hayashi; Hirotsugu Sakamoto; Yasutoshi Kobayashi; Alan Kawarai Lefor; Hironori Yamamoto
Journal:  Biomed Rep       Date:  2017-07-20

3.  One-year outcomes in children with eosinophilic esophagitis.

Authors:  Matea Kovačić; Josipa Unić; Zrinjka Mišak; Oleg Jadrešin; Vlatka Konjik; Sanja Kolaček; Iva Hojsak
Journal:  Esophagus       Date:  2018-10-19       Impact factor: 4.230

4.  Gastrointestinal symptom prevalence depends on disease duration and gastrointestinal region in type 2 diabetes mellitus.

Authors:  Midori Fujishiro; Akifumi Kushiyama; Hiroki Yamazaki; Sunao Kaneko; Yuko Koketsu; Takeshi Yamamotoya; Takako Kikuchi; Hideyuki Sakoda; Ryo Suzuki; Takashi Kadowaki
Journal:  World J Gastroenterol       Date:  2017-09-28       Impact factor: 5.742

5.  Concomitant gastrostomy tube insertion during laparoscopic Nissen fundoplication for gastro-esophageal reflux disease: analysis of risk factors for fundoplication failure.

Authors:  Louise Montalva; Aurora Mariani; Françoise Schmitt; Cécile O Muller; Khalid Alzahrani; Jérôme Viala; Alexis Mosca; Matthieu Peycelon; Arnaud Bonnard
Journal:  Surg Endosc       Date:  2020-08-24       Impact factor: 4.584

6.  Effects of acotiamide on esophageal motor function and gastroesophageal reflux in healthy volunteers.

Authors:  Norihisa Ishimura; Mami Mori; Hironobu Mikami; Shino Shimura; Goichi Uno; Masahito Aimi; Naoki Oshima; Shunji Ishihara; Yoshikazu Kinoshita
Journal:  BMC Gastroenterol       Date:  2015-09-11       Impact factor: 3.067

7.  Screening and Identifying Erosive Esophagitis in Children with Non-cardiac Chest Pain.

Authors:  Hye Won Park; You Jin Choi; Su Jin Jeong
Journal:  J Korean Med Sci       Date:  2016-01-14       Impact factor: 2.153

8.  Small Intestinal Bacterial Overgrowth in Patients with Refractory Functional Gastrointestinal Disorders.

Authors:  Shino Shimura; Norihisa Ishimura; Hironobu Mikami; Eiko Okimoto; Goichi Uno; Yuji Tamagawa; Masahito Aimi; Naoki Oshima; Shuichi Sato; Shunji Ishihara; Yoshikazu Kinoshita
Journal:  J Neurogastroenterol Motil       Date:  2016-01-31       Impact factor: 4.924

9.  A global assessment of the male predominance in esophageal adenocarcinoma.

Authors:  Shao-Hua Xie; Jesper Lagergren
Journal:  Oncotarget       Date:  2016-06-21

10.  Association between Minimal Change Esophagitis and Gastric Dysmotility: A Single-Center Electrogastrography and Endoscopy Study in Children.

Authors:  Kyung In Lim; Sung Bo Shim; Hann Tchah; Eell Ryoo
Journal:  Pediatr Gastroenterol Hepatol Nutr       Date:  2018-01-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.